文献速递慢阻肺

肺动脉修剪与肺气肿百分比及肺功能纵向变化:COPD遗传流行病学研究

Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study.
PubMed 文献 · Chest · 2021-02-16

在COPD遗传流行病学研究中,4,227名吸烟者(41%患COPD)接受基线和5年随访,CT评估肺气肿百分比和肺动脉修剪,肺功能检测FEV1/FVC。肺动脉修剪程度越高,肺气肿进展越快(每年增加0.11个百分点/1-SD,95%CI 0.09-0.16),FEV1/FVC下降也更快(每年-0.04%/1-SD,95%CI -0.008至-0.001)。提示肺血管差异可能与疾病进展相关。

要点

  • 肺动脉修剪与肺气肿进展加速独立相关
  • 肺动脉修剪与FEV1/FVC下降更快相关
  • 肺血管改变可能是COPD进展的潜在标志

核心结论

  • 在吸烟者中,肺动脉修剪与5年内肺气肿百分比进展更快和FEV1/FVC下降更迅速相关。

研究设计与样本

  • COPD遗传流行病学研究纳入2008至2011年有或无COPD的吸烟者。
  • 基线及5年后非增强CT评估肺气肿百分比(肺 voxel < -950 HU 的百分比)。
  • 自动CT工具评估肺内动脉和静脉,肺动脉修剪定义为小动脉体积(<5 mm²横截面积)与总肺动脉体积比值降低。
  • 混合线性模型调整人口学、人体测量、吸烟和COPD,肺气肿模型还调整CT扫描仪,肺功能模型调整临床中心和基线肺气肿百分比。

主要发现

  • 基线4,227名参与者年龄60±9岁,50%女性,28%黑人,47%当前吸烟,41%患COPD。
  • 中位肺气肿百分比为2.1(IQR 0.6-6.3),5.6年内每年进展0.24个百分点(95%CI 0.22-0.26)。
  • 平均FEV1/FVC为68.5±14.2%,每年下降0.26%(95%CI -0.30至-0.23)。
  • 肺动脉修剪每增加1-SD,肺气肿百分比每年多进展0.11个百分点(95%CI 0.09-0.16),调整基线肺气肿和FEV1后仍显著。
  • 肺动脉修剪每增加1-SD,FEV1/FVC每年多下降0.04%(95%CI -0.008至-0.001)。

临床怎么用

  • 肺动脉修剪可能作为识别肺气肿和肺功能快速进展高风险吸烟者的影像标志物。
  • 在评估COPD患者疾病进展时,可关注CT肺血管改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary endothelial damage has been shown to precede the development of emphysema in animals, and vascular changes in humans have been observed in COPD and emphysema. RESEARCH QUESTION: Is intraparenchymal vascular pruning associated with longitudinal progression of emphysema on CT imaging or decline in lung function over 5 years? STUDY DESIGN AND METHODS: The Genetic Epidemiology of COPD Study enrolled ever smokers with and without COPD from 2008 through 2011. The percentage of emphysema-like lung, or "percent emphysema," was assessed at baseline and after 5 years on noncontrast CT imaging as the percentage of lung voxels < -950 Hounsfield units. An automated CT imaging-based tool assessed and classified intrapulmonary arteries and veins. Spirometry measures are postbronchodilator. Pulmonary arterial pruning was defined as a lower ratio of small artery volume (< 5 mm2 cross-sectional area) to total lung artery volume. Mixed linear models included demographics, anthropomorphics, smoking, and COPD, with emphysema models also adjusting for CT imaging scanner and lung function models adjusting for clinical center and baseline percent emphysema. RESULTS: At baseline, the 4,227 participants were 60 ± 9 years of age, 50% were women, 28% were Black, 47% were current smokers, and 41% had COPD. Median percent emphysema was 2.1 (interquartile range, 0.6-6.3) and progressed 0.24 percentage points/y (95% CI, 0.22-0.26 percentage points/y) over 5.6 years. Mean FEV1 to FVC ratio was 68.5 ± 14.2% and declined 0.26%/y (95% CI, -0.30 to -0.23%/y). Greater pulmonary arterial pruning was associated with more rapid progression of percent emphysema (0.11 percentage points/y per 1-SD increase in arterial pruning; 95% CI, 0.09-0.16 percentage points/y), including after adjusting for baseline percent emphysema and FEV1. Arterial pruning also was associated with a faster decline in FEV1 to FVC ratio (-0.04%/y per 1-SD increase in arterial pruning; 95% CI, -0.008 to -0.001%/y). INTERPRETATION: Pulmonary arterial pruning was associated with faster progression of percent emphysema and more rapid decline in FEV1 to FVC ratio over 5 years in ever smokers, suggesting that pulmonary vascular differences may be relevant in disease progression. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00608764; URL: www.clinicaltrials.gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Pistenmaa CL, Nardelli P, Ash SY, et al. Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study. Chest. 2021. PMID: 33607083. doi:10.1016/j.chest.2021.01.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。